Cardinal Health, Inc.
US · LEI CCU46N3GJMF4OK4N7U60 · Figures of the company
Cardinal Health, Inc.: 6 links from the documents of the companies and the register.
Lenders 2
| Entity | Figure | Evidence | Documents |
|---|---|---|---|
| Credit Agricole Corporate and Investment Bank | Named as a lender under 1 agreement | Stated | Third Amended and Restated Five-Year Credit Agreement of 27 February 2023 |
| JPMorgan Chase Bank, N.A. | Named as a lender under 1 agreement | Stated | Third Amended and Restated Five-Year Credit Agreement of 27 February 2023 |
Customers 2
| Entity | Figure | Evidence | Documents |
|---|---|---|---|
| CVS Health Corporation | 28% of the revenue of the segment Pharmaceutical and Specialty Solutions, fiscal year ended 30 Jun 2026 | Stated | Form 10-K for the fiscal year ended 30 June 2026 |
| OptumRx | 17% of the revenue of the segment Pharmaceutical and Specialty Solutions, fiscal year ended 30 Jun 2024 | Stated | Form 10-K for the fiscal year ended 30 June 2026 |
Suppliers 2
| Entity | Figure | Evidence | Documents |
|---|---|---|---|
| Bristol-Myers Squibb Company | 22% of the revenue of the supplier, fiscal year ended 31 Dec 2025 | Stated | Form 10-K for the fiscal year ended 31 December 2025 |
| Pfizer Inc. | 13% of the revenue of the supplier, fiscal year ended 31 Dec 2025 | Stated | Form 10-K for the fiscal year ended 31 December 2025 |
Each link names the documents that state it, with the class of its evidence: stated by one party, confirmed by both, or stated by the register of legal entities. A commitment is the commitment at the date of the agreement.